IL-3 has a dual role in myeloma bone disease; apart from stimulating the bone resorption, IL-3 can also inhibit the differentiation of preosteoblast at concentrations similar to those seen in BM plasma from MM patients [22, 33]. Here, IL3 is linked to Miyoshi myopathy.